GoalVest Advisory »

Capricor Therapeutics shares owned by GoalVest Advisory

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by GoalVest Advisory from 13F filings

Historical chart of GoalVest Advisory investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by GoalVest Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by GoalVest Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $59k 2.1k 28.86

More positions owned by GoalVest Advisory

Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
State Street Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Goldman Sachs Municipal Income Etf Etf (GMUB)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Total Stock Market Etf Etf (VTI)
State Street Spdr Nyse Technology Etf Etf (XNTK)
Vanguard Ftse Europe Etf Etf (VGK)
Goldman Sachs Physical Gold Etf Etf (AAAU)
Palantir Technologies Inc Cl A Stock (PLTR)
Invesco Senior Loan Etf Etf (BKLN)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Tesla Stock (TSLA)
Microsoft Corp Stock (MSFT)

View all positions for GoalVest Advisory

Top funds holding Capricor Therapeutics

BlackRock
Vanguard Group
Susquehanna International
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
LMR Partners
J. Goldman & Co
Pier Capital
DG Capital Management
Ikarian Capital
Millennium Management
National Bank Of Canada /fi/
Two Sigma Investments

View all funds holding Capricor Therapeutics